Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MEDICAL HEALTH LAB INC

NPI: 1104839380 · SUGAR LAND, TX 77479 · Clinical Medical Laboratory · NPI assigned 08/15/2006

$48K
Total Medicaid Paid
3,936
Total Claims
3,607
Beneficiaries
52
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialRIZVI, SYED (OWNER)
NPI Enumeration Date08/15/2006

Related Entities

Other providers sharing the same authorized official: RIZVI, SYED

ProviderCityStateTotal Paid
DR. SYED S.RIZVI DDS. A PROFESSIONAL CORPORATION STOCKTON CA $6.72M
VALLEY OB/GYN MEDICAL GROUP,INC. HEMET CA $5.75M
SYED M RIZVI MD LLC MEDIA PA $91K
REMEDIAL MEDICAL SERVICES INC RIVERSIDE CA $75K
EMPOWER MEDICAL GROUP INC ORANGE CA $48K
PULMONARY SLEEP AND CRITICAL CARE SPECIALISTS OF NORTH TEXAS, PA DECATUR TX $24K
S M HAMMAD RIZVI M D INC UPLAND CA $18K
SOUTHERN HEALTHCARE SERVICES LLC HOUSTON TX $6K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 390 $0.00
2019 172 $0.00
2020 946 $683.68
2021 564 $1K
2022 186 $737.03
2024 1,678 $46K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 179 167 $12K
87481 124 115 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 198 172 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 189 175 $5K
87653 135 124 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 132 121 $2K
87500 131 120 $2K
87641 131 120 $2K
87640 132 121 $1K
87529 59 51 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 59 51 $931.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 59 51 $931.00
87563 59 51 $931.00
87511 59 51 $813.08
80061 Lipid panel 275 255 $693.02
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 59 51 $648.79
83036 Hemoglobin; glycosylated (A1C) 246 225 $490.66
80053 Comprehensive metabolic panel 236 221 $320.04
80050 General health panel 14 14 $247.93
85025 Blood count; complete (CBC), automated, and automated differential WBC count 233 216 $233.17
84443 Thyroid stimulating hormone (TSH) 126 122 $183.40
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 14 13 $172.43
82565 86 84 $55.61
84436 22 20 $27.34
82575 57 51 $27.27
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 15 13 $24.35
36415 Collection of venous blood by venipuncture 230 225 $0.00
80349 26 24 $0.00
80358 27 24 $0.00
83520 42 42 $0.00
80368 26 23 $0.00
80363 27 24 $0.00
80353 27 24 $0.00
80359 27 24 $0.00
80357 27 24 $0.00
80367 27 24 $0.00
80324 26 23 $0.00
80338 27 24 $0.00
80372 27 24 $0.00
80348 27 24 $0.00
80346 27 24 $0.00
83992 21 19 $0.00
80336 27 24 $0.00
80373 27 24 $0.00
80366 28 24 $0.00
80355 26 23 $0.00
80356 27 24 $0.00
80354 27 24 $0.00
80370 27 24 $0.00
80365 27 24 $0.00
80360 23 21 $0.00
80361 27 24 $0.00